ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of
wafer processing solutions for semiconductor and advanced
wafer-level packaging applications, today reported financial
results for its second quarter ended June 30, 2024.
"I am pleased with our second quarter results.
We delivered record revenue, strong profitability and positive cash
flow from operations,” said ACM’s President and Chief Executive
Officer, Dr. David Wang. “We are benefiting from continued
investments by our customers, and market share gains from our
existing and new products. I am also thrilled to announce today our
new Panel Electrochemical Plating (Ultra ECP ap-p) tool, which we
believe positions ACM to participate in the growing demand for AI
solutions. Our proprietary horizontal plating enables advanced
packaging with sub-micron features on square panels, which is
especially applicable to GPUs and high-density high bandwidth
memory (HBM). We are also making good progress with our global
development activities, and we recently entered into an agreement
to purchase a R&D facility with a clean room in Oregon, to
expand our U.S. footprint to help accelerate our new customer
initiatives.”
Dr. Wang continued, "We have raised our 2024
revenue outlook to reflect continued investments by our customers,
market share gains, and strong product cycles for the second half
of the year. We have also taken the opportunity to raise our
long-term revenue target to $3 billion based on increased
confidence in our new product cycles and our international
opportunities.”
|
Three Months Ended June 30, |
|
GAAP |
|
Non-GAAP(1) |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
(dollars in thousands, except EPS) |
Revenue |
$ |
202,480 |
|
|
$ |
144,577 |
|
|
$ |
202,480 |
|
|
$ |
144,577 |
|
Gross margin |
|
47.8 |
% |
|
|
47.5 |
% |
|
|
48.2 |
% |
|
|
47.6 |
% |
Income from operations |
$ |
37,593 |
|
|
$ |
30,430 |
|
|
$ |
51,935 |
|
|
$ |
32,447 |
|
Net income attributable to ACM
Research, Inc. |
$ |
24,210 |
|
|
$ |
26,825 |
|
|
$ |
37,521 |
|
|
$ |
31,297 |
|
Basic EPS |
$ |
0.39 |
|
|
$ |
0.45 |
|
|
$ |
0.60 |
|
|
$ |
0.52 |
|
Diluted EPS |
$ |
0.35 |
|
|
$ |
0.41 |
|
|
$ |
0.55 |
|
|
$ |
0.48 |
|
|
Six Months Ended June 30, |
|
GAAP |
|
Non-GAAP(1) |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
(dollars in thousands, except EPS) |
Revenue |
$ |
354,671 |
|
|
$ |
218,833 |
|
|
$ |
354,671 |
|
|
$ |
218,833 |
|
Gross margin |
|
49.6 |
% |
|
|
49.6 |
% |
|
|
50.0 |
% |
|
|
49.8 |
% |
Income from operations |
$ |
62,825 |
|
|
$ |
39,292 |
|
|
$ |
91,736 |
|
|
$ |
43,377 |
|
Net income attributable to ACM
Research, Inc. |
$ |
41,643 |
|
|
$ |
33,970 |
|
|
$ |
72,118 |
|
|
$ |
41,164 |
|
Basic EPS |
$ |
0.67 |
|
|
$ |
0.57 |
|
|
$ |
1.17 |
|
|
$ |
0.69 |
|
Diluted EPS |
$ |
0.61 |
|
|
$ |
0.52 |
|
|
$ |
1.07 |
|
|
$ |
0.63 |
|
(1) |
Reconciliations to U.S. generally accepted accounting principles
(“GAAP”) financial measures from non-GAAP financial measures are
presented below under “Reconciliation of GAAP to Non-GAAP Financial
Measures.” Non-GAAP financial measures exclude stock-based
compensation and, with respect to net income (loss) attributable to
ACM Research, Inc. and basic and diluted earnings per share, also
exclude unrealized gain (loss) on short-term investments. |
Outlook
ACM is increasing its revenue guidance for
fiscal year 2024 to a range of $695 million to $735 million from
the prior range of $650 million to $725 million. This expectation
is based on ACM management’s current assessment of the continuing
impact from international trade policy, together with various
expected spending scenarios of key customers, supply chain
constraints, and the timing of acceptances for first tools under
evaluation in the field, among other factors.
Operating Highlights and Recent
Announcements
-
Shipments. Total shipments in the second quarter
of 2024 were $202.5 million, up 32% from the second quarter of
2023. Total shipments include deliveries for revenue in the quarter
and deliveries of first tool systems awaiting customer acceptance
for potential revenue in future quarters.
- Introduced
New Panel ECP Plating Tool to Strengthen FOPLP Portfolio.
ACM introduced its new Panel Electrochemical Plating (Ultra ECP
ap-p) tool designed for fan-out panel-level packaging (FOPLP). This
new tool employs a horizontal plating approach and integrates ACM’s
proprietary multi-anode technology, achieving uniformity and
precision across the entire panel.
- Entered
FOPLP Market with Introduction of Ultra C vac-p Flux Cleaning Tool
for Chiplets. ACM announced the Ultra C vac-p flux
cleaning tool for fan-out panel-level packaging (FOPLP). Utilizing
vacuum technology, the new tool efficiently removes flux residues
from chiplet structures. ACM also announced it received a purchase
order from a new China semiconductor manufacturer which has been
shipped to the customer’s facility in July.
- Received
Order from U.S.-based Foundry and Wafer-level packing (WLP)
Customer for an advanced packaging tool to be delivered to
their U.S. facility in the first half of 2025.
- Entered
Agreement to Purchase a Clean Room in Hillsboro Oregon. On
July 30, 2024, ACM entered into an agreement to purchase a 39,500
square foot facility, including a 5,200 square foot functional
clean room. This facility is intended to replace ACM’s current
Oregon facility and further expand R&D and demonstration
capability in the U.S. market. The purchase is scheduled to close
in the fourth quarter of 2024.
- New
General Counsel and Vice President of Corporate Strategy.
ACM announced the appointment of Howard Chen as General Counsel and
Vice President of Corporate Strategy, effective July 1, 2024.
Second Quarter 2024 Financial Summary
Unless otherwise noted, the following figures refer to the
second quarter of 2024 and comparisons are with the second quarter
of 2023.
-
Revenue was $202.5 million, up 40%, reflecting
higher sales of single wafer cleaning, Tahoe and semi-critical
cleaning equipment and ECP (front-end and packaging), furnace and
other technologies, partly offset by lower sales of advanced
packaging (excluding ECP), services & spares.
- Gross
margin was 47.8% versus 47.5%. Non-GAAP gross margin,
which excludes stock-based compensation, was 48.2%% versus 47.6%.
Gross margin exceeded ACM’s long-term business model range of 40%
to 45%. ACM expects gross margin to vary from period to period due
to a variety of factors, such as product mix, currency impacts and
sales volume.
- Operating
expenses were $59.2 million, an increase of 55%. Operating
expenses as a percentage of revenue increased to 29.2% from 26.4%.
Non-GAAP operating expenses, which exclude the effect of
stock-based compensation, were $45.6 million, up 25.7%. Non-GAAP
operating expenses as a percentage of revenue decreased to 22.5%
from 25.1%.
- Operating
income was $37.6 million, compared to $30.4 million.
Operating margin was 18.6% compared to 21.0%. Non-GAAP operating
income, which excludes the effect of stock-based compensation, was
$51.9 million, compared to $32.4 million. Non-GAAP operating
margin, which excludes stock-based compensation, was 25.6% compared
to 22.4%.
- Unrealized
gain (loss) on short-term investments was $1.0 million,
compared to $(2.5) million. Unrealized gain (loss) reflects the
change in market value of the investments by ACM’s principal
operating subsidiary, ACM Research (Shanghai), Inc., in short-term
investments. The value is marked-to-market quarterly and is
excluded in the non-GAAP financial metrics.
- Income tax
expense was $9.3 million, compared to $7.6 million.
- Net income
attributable to ACM Research, Inc. was $24.2 million,
compared to $26.8 million. Non-GAAP net income attributable to ACM
Research, Inc., which excludes the effect of stock-based
compensation and unrealized gain on short-term investments, was
$37.5 million, compared to $31.3 million.
- Net income
per diluted share attributable to ACM Research, Inc. was
$0.35, compared to $0.41. Non-GAAP net income per diluted share,
which excludes the effect of stock-based compensation and
unrealized gain on short-term investments, was $0.55, compared to
$0.48.
- Cash and
cash equivalents, plus restricted cash and short-term and
long-term time deposits were $366.8 million at June 30, 2024,
compared to $288.3 million at March 31, 2024.
Conference Call Details
A conference call to discuss results will be
held on Wednesday, August 7, 2024, at 8:00 a.m. Eastern Time (8:00
p.m. China Time). To join the conference call via telephone,
participants must use the following link to complete an online
registration process. Upon registering, each participant will
receive email instructions to access the conference call, including
dial-in information and a PIN number allowing access to the
conference call. This pre-registration process is designed by the
operator to reduce delays due to operator congestion when accessing
the live call.
Online Registration:
https://register.vevent.com/register/BIcf4dbc584cf54892966d5353590ab648
Participants who have not pre-registered may
join the webcast by accessing the link at
ir.acmrcsh.com/events.
A live and archived webcast will be available on
the Investors section of the ACM website at www.acmrcsh.com.
Use of Non-GAAP Financial
Measures
ACM presents non-GAAP gross margin, operating
expenses, operating income, net income attributable to ACM
Research, Inc. and basic and diluted earnings per share as
supplemental measures to GAAP financial measures regarding ACM’s
operational performance. These supplemental measures exclude the
impact of stock-based compensation, which ACM does not believe is
indicative of its core operating results. In addition, non-GAAP net
income attributable to ACM Research, Inc. and basic and diluted
earnings per share exclude the effect of stock-based compensation
and unrealized gain (loss) on short-term investments, which ACM
also believes are not indicative of its core operating results. A
reconciliation of each non-GAAP financial measure to the most
directly comparable GAAP financial measure is provided below under
“Reconciliation of GAAP to non-GAAP Financial Measures.”
ACM believes these non-GAAP financial measures
are useful to investors in assessing its operating performance. ACM
uses these financial measures internally to evaluate its operating
performance and for planning and forecasting of future periods.
Financial analysts may focus on and publish both historical results
and future projections based on the non-GAAP financial measures.
ACM also believes it is in the best interests of investors for ACM
to provide this non-GAAP information.
While ACM believes these non-GAAP financial
measures provide useful supplemental information to investors,
there are limitations associated with the use of these non-GAAP
financial measures. These non-GAAP financial measures may not be
reported by competitors, and they may not be directly comparable to
similarly titled measures of other companies due to differences in
calculation methodologies. The non-GAAP financial measures are not
an alternative to GAAP information and are not meant to be
considered in isolation or as a substitute for comparable GAAP
financial measures. They should be used only as a supplement to
GAAP information and should be considered only in conjunction with
ACM’s consolidated financial statements prepared in accordance with
GAAP.
Forward-Looking Statements
Certain statements contained in this press
release are not historical facts and may be forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Words such as “plans,” “expects,” “believes,”
“anticipates,” “designed,” and similar words are intended to
identify forward-looking statements. Forward-looking statements are
based on ACM management’s current expectations and beliefs, and
involve a number of risks and uncertainties that are difficult to
predict and that could cause actual results to differ materially
from those stated or implied by the forward-looking statements. A
description of certain of these risks, uncertainties and other
matters can be found in filings ACM makes with the U.S. Securities
and Exchange Commission, all of which are available at www.sec.gov.
Because forward-looking statements involve risks and uncertainties,
actual results and events may differ materially from results and
events currently expected by ACM. Readers are cautioned not to
place undue reliance on these forward-looking statements, which
speak only as of the date hereof. ACM undertakes no obligation to
publicly update these forward-looking statements to reflect events
or circumstances that occur after the date hereof or to reflect any
change in its expectations with regard to these forward-looking
statements or the occurrence of unanticipated events.
About ACM Research, Inc.
ACM develops, manufactures and sells
semiconductor process equipment for single-wafer or batch wet
cleaning, electroplating, stress-free polishing, vertical furnace
processes, Track and PECVD, which are critical to advanced
semiconductor device manufacturing and wafer-level packaging. ACM
is committed to delivering customized, high performance,
cost-effective process solutions that semiconductor manufacturers
can use in numerous manufacturing steps to improve productivity and
product yield.
© ACM Research, Inc. ULTRA C and the ACM
Research logo are trademarks of ACM Research, Inc. For convenience,
these trademarks appear in this press release without ™ symbols,
but that practice does not mean that ACM will not assert, to the
fullest extent under applicable law, its rights to the
trademarks.
For investor and media inquiries, please
contact:
In
the United States: |
The Blueshirt Group |
|
Steven C. Pelayo, CFA |
|
(360)808-5154 |
|
steven@blueshirtgroup.co |
|
|
In China: |
The Blueshirt Group Asia |
|
Gary Dvorchak, CFA |
|
+86 (138) 1079-1480 |
|
gary@blueshirtgroup.co |
ACM RESEARCH, INC.Condensed Consolidated Balance
Sheets |
|
June 30, 2024 |
|
December 31, 2023 |
|
(Unaudited) |
|
|
|
(In thousands, except for per share data) |
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
$ |
324,031 |
|
|
$ |
182,090 |
|
Restricted cash |
|
881 |
|
|
|
1,083 |
|
Short-term time deposits |
|
27,183 |
|
|
|
80,524 |
|
Short-term investment |
|
19,597 |
|
|
|
21,312 |
|
Accounts receivable, net |
|
293,499 |
|
|
|
283,186 |
|
Other receivables |
|
53,694 |
|
|
|
40,065 |
|
Inventories, net |
|
602,927 |
|
|
|
545,395 |
|
Advances to related party |
|
2,756 |
|
|
|
2,432 |
|
Prepaid expenses |
|
18,594 |
|
|
|
20,023 |
|
Total current assets |
|
1,343,162 |
|
|
|
1,176,110 |
|
Property, plant and equipment,
net |
|
228,731 |
|
|
|
201,848 |
|
Land use right, net |
|
8,225 |
|
|
|
8,367 |
|
Operating lease right-of-use
assets, net |
|
6,252 |
|
|
|
7,026 |
|
Intangible assets, net |
|
2,836 |
|
|
|
2,538 |
|
Long-term time deposits |
|
14,656 |
|
|
|
40,818 |
|
Deferred tax assets |
|
20,898 |
|
|
|
20,271 |
|
Long-term investments |
|
31,898 |
|
|
|
27,880 |
|
Other long-term assets |
|
10,917 |
|
|
|
6,050 |
|
Total assets |
$ |
1,667,575 |
|
|
$ |
1,490,908 |
|
Liabilities and Equity |
|
|
|
Current liabilities: |
|
|
|
Short-term borrowings |
$ |
54,439 |
|
|
$ |
31,335 |
|
Current portion of long-term
borrowings |
|
19,671 |
|
|
|
6,783 |
|
Related party accounts
payable |
|
18,012 |
|
|
|
11,407 |
|
Accounts payable |
|
142,418 |
|
|
|
141,814 |
|
Advances from customers |
|
205,609 |
|
|
|
181,368 |
|
Deferred revenue |
|
5,279 |
|
|
|
3,687 |
|
Income taxes payable |
|
11,136 |
|
|
|
6,401 |
|
FIN-48 payable |
|
12,093 |
|
|
|
12,149 |
|
Other payables and accrued
expenses |
|
114,940 |
|
|
|
102,951 |
|
Current portion of operating
lease liability |
|
2,573 |
|
|
|
2,764 |
|
Total current liabilities |
|
586,170 |
|
|
|
500,659 |
|
Long-term borrowings |
|
70,833 |
|
|
|
53,952 |
|
Long-term operating lease
liability |
|
3,679 |
|
|
|
4,262 |
|
Other long-term liabilities |
|
5,505 |
|
|
|
5,873 |
|
Total liabilities |
|
666,187 |
|
|
|
564,746 |
|
Commitments and
contingencies |
|
|
|
Equity: |
|
|
|
Stockholders’ equity: |
|
|
|
Class A Common stock |
|
6 |
|
|
|
6 |
|
Class B Common stock |
|
1 |
|
|
|
1 |
|
Additional paid-in
capital |
|
659,462 |
|
|
|
629,845 |
|
Retained earnings |
|
198,470 |
|
|
|
156,827 |
|
Statutory surplus reserve |
|
30,060 |
|
|
|
30,060 |
|
Accumulated other
comprehensive loss |
|
(54,830 |
) |
|
|
(49,349 |
) |
Total ACM Research,
Inc. stockholders’ equity |
|
833,169 |
|
|
|
767,390 |
|
Non-controlling interests |
|
168,219 |
|
|
|
158,772 |
|
Total
equity |
|
1,001,388 |
|
|
|
926,162 |
|
Total liabilities and equity |
$ |
1,667,575 |
|
|
$ |
1,490,908 |
|
ACM RESEARCH, INC.Condensed Consolidated
Statements of Operations and Comprehensive Income (Loss) |
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
(Unaudited) |
|
( In thousands, except share and per share data) |
Revenue |
$ |
202,480 |
|
|
$ |
144,577 |
|
|
$ |
354,671 |
|
|
$ |
218,833 |
|
Cost of revenue |
|
105,696 |
|
|
|
75,938 |
|
|
|
178,766 |
|
|
|
110,208 |
|
Gross profit |
|
96,784 |
|
|
|
68,639 |
|
|
|
175,905 |
|
|
|
108,625 |
|
Operating expenses: |
|
|
|
|
|
|
|
Sales and marketing |
|
17,135 |
|
|
|
11,439 |
|
|
|
31,308 |
|
|
|
20,776 |
|
Research and development |
|
25,968 |
|
|
|
20,064 |
|
|
|
49,886 |
|
|
|
34,093 |
|
General and administrative |
|
16,088 |
|
|
|
6,706 |
|
|
|
31,886 |
|
|
|
14,464 |
|
Total operating expenses |
|
59,191 |
|
|
|
38,209 |
|
|
|
113,080 |
|
|
|
69,333 |
|
Income from operations |
|
37,593 |
|
|
|
30,430 |
|
|
|
62,825 |
|
|
|
39,292 |
|
Interest income |
|
2,381 |
|
|
|
2,346 |
|
|
|
4,155 |
|
|
|
4,131 |
|
Interest expense |
|
(932 |
) |
|
|
(649 |
) |
|
|
(1,715 |
) |
|
|
(1,344 |
) |
Realized gain from sale of
short-term investments |
|
- |
|
|
|
3,919 |
|
|
|
273 |
|
|
|
7,913 |
|
Unrealized gain (loss) on
short-term investments |
|
1,031 |
|
|
|
(2,455 |
) |
|
|
(1,564 |
) |
|
|
(3,109 |
) |
Other income (expense),
net |
|
1,357 |
|
|
|
3,724 |
|
|
|
4,437 |
|
|
|
2,306 |
|
Gain (loss) from equity method
investments |
|
(695 |
) |
|
|
3,920 |
|
|
|
(1,215 |
) |
|
|
3,888 |
|
Income before income taxes |
|
40,735 |
|
|
|
41,235 |
|
|
|
67,196 |
|
|
|
53,077 |
|
Income tax expense |
|
(9,336 |
) |
|
|
(7,638 |
) |
|
|
(13,705 |
) |
|
|
(10,517 |
) |
Net income |
|
31,399 |
|
|
|
33,597 |
|
|
|
53,491 |
|
|
|
42,560 |
|
Less: Net income attributable
to non-controlling interests |
|
7,189 |
|
|
|
6,772 |
|
|
|
11,848 |
|
|
|
8,590 |
|
Net income attributable to ACM Research, Inc. |
$ |
24,210 |
|
|
$ |
26,825 |
|
|
$ |
41,643 |
|
|
$ |
33,970 |
|
Comprehensive income
(loss): |
|
|
|
|
|
|
|
Net income |
|
31,399 |
|
|
|
33,597 |
|
|
|
53,491 |
|
|
|
42,560 |
|
Foreign currency translation adjustment, net of
tax |
|
116 |
|
|
|
(35,269 |
) |
|
|
(6,713 |
) |
|
|
(25,846 |
) |
Comprehensive Income |
|
31,515 |
|
|
|
(1,672 |
) |
|
|
46,778 |
|
|
|
16,714 |
|
Less: Comprehensive income
attributable to non-controlling interests |
|
7,210 |
|
|
|
652 |
|
|
|
10,616 |
|
|
|
4,114 |
|
Comprehensive income attributable to ACM Research,
Inc. |
$ |
24,305 |
|
|
$ |
(2,324 |
) |
|
$ |
36,162 |
|
|
$ |
12,600 |
|
|
|
|
|
|
|
|
|
Net income attributable to ACM
Research, Inc. per common share: |
|
|
|
|
|
|
|
Basic |
$ |
0.39 |
|
|
$ |
0.45 |
|
|
$ |
0.67 |
|
|
$ |
0.57 |
|
Diluted |
$ |
0.35 |
|
|
$ |
0.41 |
|
|
$ |
0.61 |
|
|
$ |
0.52 |
|
|
|
|
|
|
|
|
|
Weighted average common shares
outstanding used in computing per share amounts: |
|
|
|
|
|
|
|
Basic |
|
62,178,369 |
|
|
|
59,898,149 |
|
|
|
61,772,776 |
|
|
|
59,817,903 |
|
Diluted |
|
67,057,846 |
|
|
|
64,929,638 |
|
|
|
66,520,706 |
|
|
|
64,968,900 |
|
ACM RESEARCH, INC.Total Revenue by Product
Category and by Region |
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
(Unaudited) |
|
($ in thousand) |
Single wafer cleaning, Tahoe and
semi-critical cleaning equipment |
$ |
153,221 |
|
$ |
112,528 |
|
$ |
262,691 |
|
$ |
149,142 |
ECP (front-end and packaging),
furnace and other technologies |
|
38,962 |
|
|
19,117 |
|
|
64,762 |
|
|
45,715 |
Advanced packaging (excluding
ECP), services & spares |
|
10,297 |
|
|
12,932 |
|
|
27,218 |
|
|
23,976 |
Total Revenue By Product
Category |
$ |
202,480 |
|
$ |
144,577 |
|
$ |
354,671 |
|
$ |
218,833 |
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
Mainland China |
$ |
196,835 |
|
$ |
134,767 |
|
$ |
348,970 |
|
$ |
207,226 |
Other Regions |
|
5,645 |
|
|
9,810 |
|
|
5,701 |
|
|
11,607 |
Total Revenue By
Region |
$ |
202,480 |
|
$ |
144,577 |
|
$ |
354,671 |
|
$ |
218,833 |
ACM RESEARCH,
INC.Reconciliation of GAAP to Non-GAAP Financial
Measures
As described under “Use of Non-GAAP Financial
Measures” above, ACM presents non-GAAP gross margin, operating
expenses, operating income, net income attributable to ACM
Research, Inc., and basic and diluted earnings per share as
supplemental measures to GAAP financial measures, each of which
excludes stock-based compensation (“SBC”) from the equivalent GAAP
financial line items. In addition, non-GAAP net income attributable
to ACM Research, Inc., and basic and diluted earnings per share
exclude unrealized gain (loss) on short-term investments. The
following tables reconcile gross margin, operating expenses,
operating income, net income attributable to ACM Research, Inc.,
and basic and diluted earnings per share to the related non-GAAP
financial measures:
|
Three Months Ended June 30, |
|
|
2024 |
|
|
|
2023 |
|
|
Actual(GAAP) |
|
SBC |
|
Other non-operating
adjustments |
|
Adjusted(Non-GAAP) |
|
Actual(GAAP) |
|
SBC |
|
Other
non-operatingadjustments |
|
Adjusted(Non-GAAP) |
|
(In thousands) |
Revenue |
$ |
202,480 |
|
|
$ |
- |
|
|
$ |
- |
|
$ |
202,480 |
|
|
$ |
144,577 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
144,577 |
|
Cost of revenue |
|
(105,696 |
) |
|
|
(792 |
) |
|
|
- |
|
|
(104,904 |
) |
|
|
(75,938 |
) |
|
|
(125 |
) |
|
|
- |
|
|
|
(75,813 |
) |
Gross profit |
|
96,784 |
|
|
|
(792 |
) |
|
|
- |
|
|
97,576 |
|
|
|
68,639 |
|
|
|
(125 |
) |
|
|
- |
|
|
|
68,764 |
|
Gross margin |
|
47.8 |
% |
|
|
0.4 |
% |
|
|
- |
|
|
48.2 |
% |
|
|
47.5 |
% |
|
|
0.1 |
% |
|
|
- |
|
|
|
47.6 |
% |
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing |
|
(17,135 |
) |
|
|
(3,024 |
) |
|
|
- |
|
|
(14,111 |
) |
|
|
(11,439 |
) |
|
|
(431 |
) |
|
|
- |
|
|
|
(11,008 |
) |
Research and development |
|
(25,968 |
) |
|
|
(4,206 |
) |
|
|
- |
|
|
(21,762 |
) |
|
|
(20,064 |
) |
|
|
(709 |
) |
|
|
- |
|
|
|
(19,355 |
) |
General and administrative |
|
(16,088 |
) |
|
|
(6,320 |
) |
|
|
- |
|
|
(9,768 |
) |
|
|
(6,706 |
) |
|
|
(752 |
) |
|
|
- |
|
|
|
(5,954 |
) |
Total operating expenses |
|
(59,191 |
) |
|
|
(13,550 |
) |
|
|
- |
|
|
(45,641 |
) |
|
|
(38,209 |
) |
|
|
(1,892 |
) |
|
|
- |
|
|
|
(36,317 |
) |
Income (loss) from
operations |
$ |
37,593 |
|
|
$ |
(14,342 |
) |
|
$ |
- |
|
$ |
51,935 |
|
|
$ |
30,430 |
|
|
$ |
(2,017 |
) |
|
$ |
- |
|
|
$ |
32,447 |
|
Unrealized gain (loss) on short-term investments |
|
1,031 |
|
|
|
- |
|
|
|
1,031 |
|
|
- |
|
|
|
(2,455 |
) |
|
|
- |
|
|
|
(2,455 |
) |
|
|
- |
|
Net income (loss)
attributable to ACM Research, Inc. |
$ |
24,210 |
|
|
$ |
(14,342 |
) |
|
$ |
1,031 |
|
$ |
37,521 |
|
|
$ |
26,825 |
|
|
$ |
(2,017 |
) |
|
$ |
(2,455 |
) |
|
$ |
31,297 |
|
Basic EPS |
$ |
0.39 |
|
|
|
|
|
|
$ |
0.60 |
|
|
$ |
0.45 |
|
|
|
|
|
|
$ |
0.52 |
|
Diluted EPS |
$ |
0.35 |
|
|
|
|
|
|
$ |
0.55 |
|
|
$ |
0.41 |
|
|
|
|
|
|
$ |
0.48 |
|
|
Six Months Ended June 30, |
|
|
2024 |
|
|
|
2023 |
|
|
Actual(GAAP) |
|
SBC |
|
Other
non-operatingadjustments |
|
Adjusted(Non-GAAP) |
|
Actual(GAAP) |
|
SBC |
|
Other
non-operatingadjustments |
|
Adjusted(Non-GAAP) |
|
(In thousands) |
Revenue |
$ |
354,671 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
354,671 |
|
|
$ |
218,833 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
218,833 |
|
Cost of revenue |
|
(178,766 |
) |
|
|
(1,573 |
) |
|
|
- |
|
|
|
(177,193 |
) |
|
|
(110,208 |
) |
|
|
(250 |
) |
|
|
- |
|
|
|
(109,958 |
) |
Gross profit |
|
175,905 |
|
|
|
(1,573 |
) |
|
|
- |
|
|
|
177,478 |
|
|
|
108,625 |
|
|
|
(250 |
) |
|
|
- |
|
|
|
108,875 |
|
Gross margin |
|
49.6 |
% |
|
|
0.4 |
% |
|
|
- |
|
|
|
50.0 |
% |
|
|
49.6 |
% |
|
|
0.1 |
% |
|
|
- |
|
|
|
49.8 |
% |
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing |
|
(31,308 |
) |
|
|
(6,051 |
) |
|
|
- |
|
|
|
(25,257 |
) |
|
|
(20,776 |
) |
|
|
(862 |
) |
|
|
- |
|
|
|
(19,914 |
) |
Research and development |
|
(49,886 |
) |
|
|
(8,709 |
) |
|
|
- |
|
|
|
(41,177 |
) |
|
|
(34,093 |
) |
|
|
(1,410 |
) |
|
|
- |
|
|
|
(32,683 |
) |
General and administrative |
|
(31,886 |
) |
|
|
(12,578 |
) |
|
|
- |
|
|
|
(19,308 |
) |
|
|
(14,464 |
) |
|
|
(1,563 |
) |
|
|
- |
|
|
|
(12,901 |
) |
Total operating expenses |
|
(113,080 |
) |
|
|
(27,338 |
) |
|
|
- |
|
|
|
(85,742 |
) |
|
|
(69,333 |
) |
|
|
(3,835 |
) |
|
|
- |
|
|
|
(65,498 |
) |
Income (loss) from
operations |
$ |
62,825 |
|
|
$ |
(28,911 |
) |
|
$ |
- |
|
|
$ |
91,736 |
|
|
$ |
39,292 |
|
|
$ |
(4,085 |
) |
|
$ |
- |
|
|
$ |
43,377 |
|
Unrealized gain (loss) on short-term investments |
|
(1,564 |
) |
|
|
- |
|
|
|
(1,564 |
) |
|
|
- |
|
|
|
(3,109 |
) |
|
|
- |
|
|
|
(3,109 |
) |
|
|
- |
|
Net income (loss)
attributable to ACM Research, Inc. |
$ |
41,643 |
|
|
$ |
(28,911 |
) |
|
$ |
(1,564 |
) |
|
$ |
72,118 |
|
|
$ |
33,970 |
|
|
$ |
(4,085 |
) |
|
$ |
(3,109 |
) |
|
$ |
41,164 |
|
Basic EPS |
$ |
0.67 |
|
|
|
|
|
|
$ |
1.17 |
|
|
$ |
0.57 |
|
|
|
|
|
|
$ |
0.69 |
|
Diluted EPS |
$ |
0.61 |
|
|
|
|
|
|
$ |
1.07 |
|
|
$ |
0.52 |
|
|
|
|
|
|
$ |
0.63 |
|
ACM Research (NASDAQ:ACMR)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
ACM Research (NASDAQ:ACMR)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025